MULTI-INSTITUTIONAL ANALYSIS OF PEDIATRIC RELAPSED/REFRACTORY CENTRAL NERVOUS SYSTEM GERMINOMA.

被引：0

作者：

McGlynn, Mary Claire ^{[1
]}

Abu-Arja, Mohammad H. ^{[2
]}

Nagabushan, Sumanth ^{[3
,4
]}

Zaghloul, Mohamed Saad ^{[5
]}

Elhemaly, Ahmed ^{[5
]}

Bertrand, Kelsey ^{[6
]}

Gajjar, Amar ^{[6
]}

Alias, Hamidah ^{[7
]}

Cappellano, Andrea ^{[8
]}

Graham, Richard ^{[9
]}

Baglivo, Sofia Jares ^{[9
]}

Bhadri, Vivek ^{[10
]}

Govender, Dinisha ^{[10
]}

Abdelbaki, Mohamed S. ^{[11
]}

机构：

[1] Washington Univ, Div Pediat Hematol Oncol & Blood & Marrow Transpl, Dept Pediat, St Louis, WA USA

[2] Texas Childrens Hosp, Div Hematol Oncol, Dept Pediat, Baylor Coll Med, Houston, TX USA

[3] Sydney Childrens Hosp, Kids Canc Ctr, Randwick, NSW, Australia

[4] Univ New South Wales, Randwick, NSW, Australia

[5] Childrens Canc Hosp Egypt, Natl Canc Inst NCI, Paediat Oncol, Cairo, Egypt

[6] St Jude Childrens Res Hosp, Memphis, TN USA

[7] Univ Kebangsaan Malysia Med Ctr, Dept Paediat, Pediat Haemato Oncol, Bangi, Malaysia

[8] Univ Fed Sao Paulo, Pediat Oncol, IOP GRAACC UNIFESP, Sao Paulo, Brazil

[9] Cincinnati Childrens Hosp, Div Pediat Oncol, Dept Pediat, Cincinnati, OH USA

[10] Univ Sydney, Childrens Hosp Westmead, Canc Ctr Children, Sydney, NSW, Australia

[11] Washington Univ, Dept Pediat, Div Pediat Hematol Oncol Blood & Marrow Transplan, St Louis, WA USA

来源：

NEURO-ONCOLOGY | 2023年 / 25卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

RARE-08

引用

页数：1

共 50 条

[31] Therapeutic management of refractory or relapsed primary central nervous system lymphomas
Reni, M
Ferreri, AJM
ANNALS OF HEMATOLOGY, 2001, 80 : B113 - B117
[32] A relapsed/refractory multiple myeloma patient with central nervous system involvement
Cifttciler, R.
Ayar, S.
Susesi, K.
Aksu, S.
Buyukasik, Y.
LEUKEMIA RESEARCH, 2019, 85 : S43 - S43
[33] Treatment and outcome of children with relapsed ependymoma: a multi-institutional retrospective analysis
Zacharoulis, Stergios
Ashley, Sue
Moreno, Lucas
Gentet, Jean-Claude
Massimino, Maura
Frappaz, Didier
CHILDS NERVOUS SYSTEM, 2010, 26 (07) : 905 - 911
[34] Ibrutinib Therapy in Relapsed/Refractory Primary Central Nervous System Lymphomas
Guven, Serkan
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S458 - S459
[35] Pemetrexed in the treatment of relapsed/refractory primary central nervous system lymphoma
Raizer, Jeffrey J.
Rademaker, Alfred
Evens, Andrew M.
Rice, Laurie
Schwartz, Margaret
Chandler, James P.
Getch, Christopher C.
Tellez, Claudia
Grimm, Sean A.
CANCER, 2012, 118 (15) : 3743 - 3748
[36] New hopes in relapsed refractory primary central nervous system lymphoma
Calimeri, Teresa
Steidl, Carolina
Fiore, Paolo
Ferreri, Andres J. M.
CURRENT OPINION IN ONCOLOGY, 2023, 35 (05) : 364 - 372
[37] Management of refractory or relapsed primary central nervous system lymphoma (Review)
Yamanaka, Ryuya
MOLECULAR MEDICINE REPORTS, 2009, 2 (06) : 879 - 885
[38] Patterns of Central Nervous System Involvement in Relapsed and Refractory Multiple Myeloma
Abdallah, Al-ola
Atrash, Shebli
Shahid, Zainab
Jameel, Muzaffar
Grazziutti, Monica
Apewokin, Senu
Kumar, Naveen S.
Restrepo, Alejandro
Waheed, Sarah
Van Rhee, Frits
Heuck, Christoph J.
Johann, Donald, Jr.
Barlogie, Bart
Usmani, Saad Z.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (03): : 211 - 214
[39] Rituximab monotherapy for relapsed or refractory primary central nervous system lymphoma
Batchelor, T. T.
Lesser, G. J.
Grossman, S. A.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[40] Therapeutic management of refractory or relapsed primary central nervous system lymphomas
Michele Reni
Andrés José María Ferreri
Annals of Hematology, 2001, 80 (Suppl 3) : B113 - B118

← 1 2 3 4 5 →